Abstract
Background: Neurosteroids, such as pregnenolone, have potential in mood disorder treatment. Because depression is associated with dysregulated connectivity in brain networks, a systems-level biomarker for neurosteroids modulation of large-scale brain networks can offer critical insight into circuits underlying treatment response. To our knowledge, no studies have examined resting-state functional connectivity (rsFC) in people with depression following pregnenolone administration.
Methods: In this crossover design study conducted between 2019–2021, women (n=29, mean age=45.6 years) with major depressive disorder (DSM-5) were randomized to 7 days of oral pregnenolone 500 mg/d, pregnenolone 800 mg/d, and placebo with a 14-day washout between conditions. After each treatment, steroid levels and resting-state fMRI (rsfMRI) data were collected. A seed-based voxel-wise analysis, with bilateral amygdala as seed, investigated rsFC alterations following treatment conditions in a per-protocol sample (n=11).
Results: Compared to placebo, pregnenolone 500 mg/d was associated with decreased connectivity between the bilateral amygdala and left frontal pole (PFDR=.011). Difference in amygdala connectivity between pregnenolone 800 mg/d and placebo was nonsignificant. Allopregnanolone serum levels increased significantly with administration of either pregnenolone dose as compared to placebo.
Conclusions: Findings suggest that pregnenolone 500 mg/d was associated with decreased connectivity between the amygdala and frontal pole, brain regions pertinent to depression and cognitive control. Presence of rsFC changes at 500 mg/d but not 800 mg/d suggests an inverted-U dose–response pattern, where moderate dosing optimally engages neural circuits compared to higher doses.
Trial Registration: ClinicalTrials.gov identifier: NCT03645096
J Clin Psychiatry 2026;87(4):26m16360
Author affiliations are listed at the end of this article.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
Members Only Content
This full article is available exclusively to Professional tier members. Subscribe now to unlock the HTML version and gain unlimited access to our entire library plus all PDFs. If you're already a subscriber, please log in below to continue reading.
References (46)
- COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712. PubMed CrossRef
- Katon W. The impact of depression on workplace functioning and disability costs. Am J Manag Care. 2009;15(11 Suppl):S322–S327. PubMed
- Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden Of Disease study 2010. PLoS Med. 2013;10(11):e1001547. PubMed CrossRef
- Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the national Epidemiologic Survey on Alcoholism and Related Conditions. Archives Gen Psychiatry. 2005;62(10):1097–1106. PubMed CrossRef
- Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105. PubMed CrossRef
- Weissman, MM, Leaf, PJ, Holzer, CE, et al. The epidemiology of depression: an update on sex differences in rates. J Affect Disord. 1984;7(3):179–188. PubMed CrossRef
- Kuehner C. Why is depression more common among women than among men?. Lancet Psychiatry. 2017;4(2):146–158. PubMed CrossRef
- Kornstein SG, Schatzberg AF, Yonkers KA, et al. Gender differences in presentation of chronic major depression. Psychopharmacol Bull. 1995;31(4):711–718. PubMed
- Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113–137. PubMed CrossRef
- Baulieu EE, Robel P. Neurosteroids: a new brain function? J Steroid Biochem Mol Biol. 1990;37(3):395–403. PubMed CrossRef
- Meltzer-Brody S, Kanes SJ. Allopregnanolone in postpartum depression: role in pathophysiology and treatment. Neurobiol Stress. 2020;12:100212. PubMed CrossRef
- Meltzer-Brody S, Colquhoun H, Riesenberg R, et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018;392(10152):1058–1070. PubMed CrossRef
- Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, et al. Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial. JAMA Psychiatry. 2021;78(9):951–959. PubMed CrossRef
- Murugan S, Jakka P, Namani S, et al. The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation. J Biol Chem. 2019;294(12):4596–4607. PubMed CrossRef
- George MS, Guidotti A, Rubinow D, et al. CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI. Biol Psychiatry. 1994;35(10):775–780. PubMed CrossRef
- Osuji IJ, Vera-Bolaños E, Carmody TJ, et al. Pregnenolone for cognition and mood in dual diagnosis patients. Psychiatry Res. 2010;178(2):309–312. PubMed CrossRef
- Brown ES, Park J, Marx CE, et al. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology. 2014;39(12):2867–2873. PubMed CrossRef
- Sripada RK, Welsh RC, Marx CE, et al. The neurosteroids allopregnanolone and dehydroepiandrosterone modulate resting-state amygdala connectivity. Hum Brain Mapp. 2014;35(7):3249–3261. PubMed CrossRef
- Wang X, Nie X, Zhang F, et al. Functional magnetic resonance imaging of depression: a bibliometrics and meta-analysis. Ann Gen Psychiatry. 2024;23(1):39. PubMed CrossRef
- Deligiannidis KM, Fales CL, Kroll-Desrosiers AR, et al. Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study. Neuropsychopharmacology. 2019;44(3):546–554. PubMed CrossRef
- Guard M, Labonte AK, Mendoza M, et al. Brexanolone treatment in a real-world patient population: a case series and pilot feasibility study of precision neuroimaging. J Clin Psychopharmacol. 2024;44(3):240–249. PubMed CrossRef
- Sripada RK, Marx CE, King AP, et al. DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli. Neuropsychopharmacology. 2013;38(9):1798–1807. PubMed CrossRef
- Sripada RK, Marx CE, King AP, et al. Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits. Biol Psychiatry. 2013;73(11):1045–1053. PubMed CrossRef
- van Wingen GA, van Broekhoven F, Verkes RJ, et al. Progesterone selectively increases amygdala reactivity in women. Mol Psychiatr. 2008;13(3):325–333. PubMed CrossRef
- McGavack TH. ACTH, cortisone and pregnenolone in arthritis and allied diseases. Geriatrics. 1952;7(2):99–108. PubMed
- Freeman H, Pincus G. Oral steroid administration in rheumatoid arthritis. J Clin Endocrinol Metab. 1950;10(7):824. PubMed
- Marx CE, Trost WT, Shampine L, et al. Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. Psychopharmacology. 2006;186(3):462–472. PubMed CrossRef
- Marx, CE , Trost, WT, Shampine, LJ, et al. The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer’s disease. Biol Psychiatry. 2006;60(12):1287–1294. PubMed CrossRef
- Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22(2):343–381. PubMed
- Sergerie K, Chochol C, Armony JL. The role of the amygdala in emotional processing: a quantitative meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev. 2008;32(4):811–830. PubMed CrossRef
- Berboth S, Morawetz C. Amygdala-prefrontal connectivity during emotion regulation: a meta-analysis of psychophysiological interactions. Neuropsychologia. 2021;153:107767. PubMed CrossRef
- Bramson B, Folloni D, Verhagen L, et al. Human lateral frontal pole contributes to control over emotional approach–avoidance actions. J Neurosci. 2020;40(14): 2925–2934. PubMed CrossRef
- Paulus FW, Ohmann S, Möhler E, et al. Emotional dysregulation in children and adolescents with psychiatric disorders. A narrative review. Front Psychiatry. 2021;12:628252. PubMed CrossRef
- Thiebaut de Schotten M, Dell’Acqua F, Valabregue R, et al. Monkey to human comparative anatomy of the frontal lobe association tracts. Cortex. 2012;48(1):82–96. PubMed CrossRef
- Von Der Heide RJ, Skipper LM, Klobusicky E, et al. Dissecting the uncinate fasciculus: disorders, controversies and a hypothesis. Brain. 2013;136(Pt 6): 1692–1707. PubMed CrossRef
- Xu EP, Nguyen L, Leibenluft E, et al. A meta-analysis on the uncinate fasciculus in depression. Psychol Med. 2023;53(7):2721–2731. PubMed CrossRef
- Beauchamp MH, Ormerod BK, Jhamandas K, et al. Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats. Pharmacol, Biochem Behav. 2000;67(1):29–35. PubMed CrossRef
- Meziane H, Mathis C, Paul SM, et al. The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task. Psychopharmacology. 1996;126(4): 323–330. PubMed CrossRef
- Andréen L, Sundström-Poromaa I, Bixo M, et al. Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology. 2006;187(2):209–221. PubMed CrossRef
- Sigel E, Baur R. Allosteric modulation by benzodiazepine receptor ligands of the GABAA receptor channel expressed in Xenopus oocytes. J Neurosci. 1988;8(1): 289–295. PubMed
- Wang DS, Lu SY, Hong Z, et al. Biphasic action of midazolam on GABAA receptor-mediated responses in rat sacral dorsal commissural neurons. Biochem Biophys Res Commun. 2003;309(4):893–899. PubMed CrossRef
- Gjedde A, Kumakura Y, Cumming P, et al. Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proc Natl Acad Sci. 2010;107(8):3870–3875. PubMed CrossRef
- Cohen S, Janicki-Deverts D, Doyle WJ, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci. 2012;109(16):5995–5999. PubMed CrossRef
- Naylor, JC , Kilts, JD, Shampine, LJ, et al. Effect of pregnenolone vs placebo on self-reported chronic low back pain among US military veterans: a randomized clinical trial. JAMA Netw Open. 2020;3(3):e200287. PubMed CrossRef
- Marx CE, Lee J, Subramaniam M, et al. Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia. Psychopharmacology. 2014;231(17): 3647–3662. PubMed CrossRef
- Milivojevic V, Charron L, Fogelman N, et al. Pregnenolone reduces stress-induced craving, anxiety, and autonomic arousal in individuals with cocaine use disorder. Biomolecules. 2022;12(11):1593. PubMed CrossRef